Abstract
Cystic Fibrosis (CF) is a common, ultimately fatal, inherited disorder of exocrine glands. The dominant clinical feature is a chronic progressive lung disease mediated by airways infection and inflammation. The most important pathogen in the lungs is Pseudomonas aeruginosa (P. aeruginosa). Eventually more than 80 percent of all CF individuals are chronically infected with this organism. The responsible gene, named the CF Transmembrane Regulator (CFTR), was identified in 1989. Although our understanding of the disease has increased, treatment is symptomatic and the details of pathogenesis at the molecular level remain to be elucidated. The decreased conductance of chloride at the surface of airway epithelial cells is the most characteristic pathophysiologic abnormality and is the target of much of the research to develop new therapies. Shortly after the identification of the sweat chloride defect in CF, biochemical analysis of mucins defined an altered carbohydrate composition of CF mucins when compared to controls. The altered terminal glycosylation of CF glycoproteins has been described by many investigators, although there is not a consensus. Since the recent determination of the crystal structure of the major binding protein of P. aeruginosa – (PA-IIL) and the demonstration of its high affinity binding to the same fucosylated oligosaccharides (Lewis x and Lewis a) that are characteristic of the CF glycophenotype, there has been a renewed interest in the role of altered terminal glycosylation in the pathogenesis of CF. This review will provide an update of studies on the altered terminal glycosylation in CF and will discuss the possible role of glycosylation in the pathogenesis of the pulmonary infection in CF and its link to CFTR function.
Current Organic Chemistry
Title: Cystic Fibrosis (CF), Pseudomonas aeruginosa, CFTR and the CF Glycosylation Phenotype: A Review and Update
Volume: 12 Issue: 11
Author(s): L. I. Stoykova and T. F. Scanlin
Affiliation:
Abstract: Cystic Fibrosis (CF) is a common, ultimately fatal, inherited disorder of exocrine glands. The dominant clinical feature is a chronic progressive lung disease mediated by airways infection and inflammation. The most important pathogen in the lungs is Pseudomonas aeruginosa (P. aeruginosa). Eventually more than 80 percent of all CF individuals are chronically infected with this organism. The responsible gene, named the CF Transmembrane Regulator (CFTR), was identified in 1989. Although our understanding of the disease has increased, treatment is symptomatic and the details of pathogenesis at the molecular level remain to be elucidated. The decreased conductance of chloride at the surface of airway epithelial cells is the most characteristic pathophysiologic abnormality and is the target of much of the research to develop new therapies. Shortly after the identification of the sweat chloride defect in CF, biochemical analysis of mucins defined an altered carbohydrate composition of CF mucins when compared to controls. The altered terminal glycosylation of CF glycoproteins has been described by many investigators, although there is not a consensus. Since the recent determination of the crystal structure of the major binding protein of P. aeruginosa – (PA-IIL) and the demonstration of its high affinity binding to the same fucosylated oligosaccharides (Lewis x and Lewis a) that are characteristic of the CF glycophenotype, there has been a renewed interest in the role of altered terminal glycosylation in the pathogenesis of CF. This review will provide an update of studies on the altered terminal glycosylation in CF and will discuss the possible role of glycosylation in the pathogenesis of the pulmonary infection in CF and its link to CFTR function.
Export Options
About this article
Cite this article as:
Stoykova I. L. and Scanlin F. T., Cystic Fibrosis (CF), Pseudomonas aeruginosa, CFTR and the CF Glycosylation Phenotype: A Review and Update, Current Organic Chemistry 2008; 12 (11) . https://dx.doi.org/10.2174/138527208784892169
DOI https://dx.doi.org/10.2174/138527208784892169 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Withdrawal Notice: Molecular Mechanism of TLR4 Mediated T Cell Immune Effect in Transfusion-induced Acute Lung Injury based on Slit2/Robo4 Signaling Pathway
Current Molecular Pharmacology Targeted Drug Delivery to the Virus-Infected Airway; Complications and Remedies
Current Drug Delivery Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Genomic Expression in the Epileptogenic Hippocampus and Psychiatric Co-Morbidities
Current Psychiatry Reviews Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy
Current Diabetes Reviews Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
Current Cancer Drug Targets Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Current Drug Targets Applications of Umbilical Cord Derived Mesenchymal Stem Cells in Autoimmune and Immunological Disorders: From Literature to Clinical Practice
Current Stem Cell Research & Therapy Cognitive Impairment in the Septic Brain
Current Neurovascular Research Molecular Imaging of Vascular Inflammation
Current Pharmaceutical Design An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds
Current Pharmaceutical Design Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science HCV-targeted Antivirals: Current Status and Future Challenges
Current Pharmaceutical Design Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
Current Signal Transduction Therapy Gamma/Delta T Cell mRNA Levels Decrease at Mucosal Sites and Increase at Lymphoid Sites Following an Oral SIV Infection of Macaques
Current HIV Research Immunotherapeutic Targeting of Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) Meet Our Editorial Board Member
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Preface
Current Rheumatology Reviews Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy